Hypophosphatasia
Classification according to ICD-10 | |
---|---|
E83.38 | Disorders of phosphorus metabolism and phosphatase hypophosphatasia |
ICD-10 online (WHO version 2019) |
Hypophosphatasia ( HPP for short ) is a rare, hereditary , currently incurable disorder in bone metabolism, which manifests itself primarily in the skeletal structure . It is also referred to as Rathbun syndrome or phosphatase deficiency rickets and is often confused with other diseases such as rickets or osteoporosis or "glass bone disease" ( osteogenesis imperfecta ). However, inflammatory processes in bones, joints and muscles also lead to confusion with rheumatic diseases . The disease is autosomal - recessive inherited.
description
Several genetic specifics on chromosome 1 gene locus p34-36 are the reason that the enzyme alkaline phosphatase - more specifically, the tissue-nonspecific alkaline phosphatase ( engl. TNSALP - for tissue non-specific alkaline phosphatase ) - in too low a concentration in the organism and / or shows insufficient activity. Alkaline phosphatase ( ALP ) consists of several isoenzymes (but mostly only the total ALP in the blood is measured ), which are produced in different organs in the body and in the bones . There are specific ALPs ( intestinal type , placental type , pseudo-placental type ) and a tissue-unspecific ALP ( bone / liver / kidney type ).
Alkaline phosphatase plays an essential role in building bones. The osteoblasts , the cells that build the bones, need large amounts of alkaline phosphatase to build bones, some of which they produce themselves and some of which they take from the bloodstream. The ALP breaks down, among other things, inorganic pyrophosphate and thus wins phosphate for bone structure. Together with calcium , the bone mineral hydroxyapatite is generated in the osteoblasts . Because the alkaline phosphatase is defective in hypophosphatasia, inorganic pyrophosphate accumulates in the organism and actively inhibits further bone mineralization. At the same time, calcium and phosphate combine to form crystals outside the osteoblasts, which can also spread and be deposited in the body. By means of an autoimmune reaction, these microcrystals lead to inflammatory reactions in bones, joints and muscles. This non-bacterial inflammation of the bones and joints in particular often confuses the symptoms of hypophosphatasia with those of other diseases such as rheumatism or osteoarthritis / arthritis (and sometimes even bone cancer ).
In addition to the inorganic pyrophosphate, phosphoethanolamine and pyridoxal-5-phosphate are not converted enough in hypophosphatasia and accumulate in the blood and / or urine, where they are used for the reliable diagnosis of hypophosphatasia.
Research differentiates a total of five - according to other sources, six - course forms of hypophosphatasia, which therefore show a very large variability in terms of their clinical appearance ( phenotype ).
The consequences of the lack of alkaline phosphatase are serious for the entire body: In infancy , deformities of the skull appear due to prematurely ossified skull sutures. If the bones in the rib cage are too soft, breathing problems arise . Almost all bones can break or become deformed. This tendency increases with the mechanical load, for example when running. Since the growth plates of the bones are also affected, short stature is also a common symptom of hypophosphatasia. In some cases there is also a real short stature . However, the symptoms are not limited to the structure of the skeleton, but also affect other body functions such as digestion and nerve function . Also typical is a premature loss of both deciduous teeth and the second dentition. In some cases, calcification of the kidneys , called nephrocalcinosis, can also be observed.
Although it is inherited, hypophosphatasia can appear for the first time at any age or cause symptoms. While it is likely to be mistaken for various skeletal dysplasias in childhood , the first misdiagnosis in adult patients is usually osteoporosis .
history
In 1956 Heinz Nierhoff and Otto Huebner published a description of the infantile form of hypophosphatasia.
The outdated term Nierhoff-Huebner syndrome refers to this .
literature
- H. Orimo: The mechanism of mineralization and the role of alkaline phosphatase in health and disease. In: J Nippon Med Sch. 77, 2010, pp. 4-12. PMID 20154452
- A. Reibel et al: Orodental phenotype and genotype findings in all subtypes of hypophosphatasia. In: Orphanet Journal of Rare Diseases. 4, 2009, p. 6 PMID 19232125 ( Open Access )
- B. Bağiş et al: Prosthetic rehabilitation of hypophosphatasia: a case report. In: Cases Journal. 2, 2009, p. 7626. doi: 10.1186 / 1757-1626-2-7626 ( Open Access )
- C. Beck et al .: How can calcium pyrophosphate crystals induce inflammation in hypophosphatasia or chronic inflammatory joint disease? In: Rheumatol Int. 29, 2009, pp. 229-238. PMID 18821074
- C. Beck et al: Hypophosphatasia. In: Klin Padiatr. 221, 2009, pp. 219-226. PMID 19629901 (Review)
- C. Beck et al: Hypophosphatasia - recent advances in diagnosis and treatment. In: The Open Bone Journal. 1, 2009, pp. 8-15. doi: 10.2174 / 1876525400901010008 ( Open Access )
- C. Beck et al: Hypophosphatasia - current diagnosis and therapy. (PDF; 953 kB) In: J Miner metabolism. 16, 2009, pp. 122-127.
- H. Collmann et al .: Neurosurgical aspects of childhood hypophosphatasia. In: Child Nerv Syst. 25, 2009, pp. 217-223. PMID 18769927
- E. Mornet: Hypophosphatasia. In: Orphanet Journal of Rare Diseases. Volume 2, 2007, p. 40, doi: 10.1186 / 1750-1172-2-40 , PMID 17916236 , PMC 2164941 (free full text) (review).
- HJ Girschick et al: Chronic multifocal non-bacterial osteomyelitis in hypophosphatasia mimicking malignancy. In: BMC Pediatr. 7, 2007, p. 3. PMID 17241478 ( Open Access )
- HJ Girschick et al: Effective NSAID treatment indicates that hyperprostaglandinism is affecting the clinical severity of childhood hypophosphatasia. In: Orphanet Journal of Rare Diseases. 1, 2006, p. 24. PMID 16803637 ( Open Access )
- H. Orimo et al .: Mutational analysis and functional correlation with phenotype in German patients with childhood type hypophosphatasia. In: J Bone Miner Res 16, 2001, pp. 2313-2319. PMID 11760847
- HJ Girschick et al: Bone metabolism and bone mineral density in childhood hypophosphatasia. In: Bone. 25, 1999, pp. 361-367. PMID 10495141
- HJ Girschick et al: Treatment of childhood hypophosphatasia with nonsteroidal antiinflammatory drugs. In: Bone. 25, 1999, pp. 603-607. PMID 10574582
Individual evidence
- ↑ P. Matzen: www.hypophosphatasie.net.
- ↑ H. Nierhoff, O. Hübner: Familial systemized enchondral dysostosis in 3 siblings. In: Journal of Pediatrics. Vol. 78, No. 5, 1956, pp. 497-521, PMID 13423511 .
- ↑ Bernfried Leiber (founder): The clinical syndromes. Syndromes, sequences and symptom complexes . Ed .: G. Burg, J. Kunze, D. Pongratz, PG Scheurlen, A. Schinzel, J. Spranger. 7., completely reworked. Edition. tape 2 : symptoms . Urban & Schwarzenberg, Munich et al. 1990, ISBN 3-541-01727-9 .